Last updated: April 5, 2024
Sponsor: China Medical University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Insomnia
Treatment
Valerian
Clinical Study ID
NCT05185219
2021MenoVal / CMUH109-REC2-177
Ages 45-60 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 45〜60 years old, and is menopaused for at least 1 year。
- meet the criteria of ICSD-3 for insomnia
- PSQI > 5
Exclusion
Exclusion Criteria:
- psychiatry disease
- Heart, brain, liver diseases
- Insomnia is caused by diseases.
- Steroid used within 6 months
- pregnant or breastfeeding
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: Valerian
Phase:
Study Start date:
December 14, 2021
Estimated Completion Date:
January 20, 2025
Study Description
Connect with a study center
China Medical University
Taichung,
TaiwanActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.